Avidity Partners Management LP Abb Vie Inc. Transaction History

Avidity Partners Management LP

$1.63 Billion
Q3 2024

A detailed history of Avidity Partners Management LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 100,000 shares of ABBV stock, worth $17.6 Million. This represents 1.21% of its overall portfolio holdings.

Number of Shares

100,000

Previous 277,800 64.0%

Holding current value

$17.6 Million

Previous $47.6 Million 58.55%

% of portfolio

1.21%

Previous 2.34%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $29.1 Million - $35.4 Million	-177,800 Reduced 64.0%	100,000 $19.7 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $7.86 Million - $9.18 Million	50,800 Added 22.38%	277,800 $47.6 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $9.17 Million - $10.5 Million	-57,405 Reduced 20.18%	227,000 $41.3 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $39.1 Million - $44.1 Million	284,405 New	284,405 $44.1 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $68.7 Million - $85.5 Million	518,400 New	518,400 $69.8 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $97.9 Million - $124 Million	-711,100 Reduced 48.5%	755,000 $116 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $68.5 Million - $85 Million	-518,900 Reduced 26.14%	1,466,100 $238 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $39.9 Million - $50.5 Million	371,800 Added 23.05%	1,985,000 $269 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $13.7 Million - $15.6 Million	128,800 Added 8.68%	1,613,200 $174 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $62.4 Million - $69.5 Million	-592,800 Reduced 28.54%	1,484,400 $167 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $73.8 Million - $81.2 Million	721,200 Added 53.19%	2,077,200 $225 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $13.4 Million - $18.1 Million	-166,800 Reduced 10.95%	1,356,000 $145 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $1.94 Million - $2.28 Million	-22,600 Reduced 1.46%	1,522,800 $133 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $78.4 Million - $105 Million	1,068,400 Added 223.98%	1,545,400 $152 Million
Q1 2020 Jun 17, 2020	BUY	$64.5 - $97.79 $30.8 Million - $46.6 Million	477,000 New	477,000 $36.3 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $6.06 Million - $9.19 Million	-94,000 Closed	0 $0
Q4 2019 Jun 17, 2020	BUY	$72.13 - $90.25 $6.78 Million - $8.48 Million	94,000 New	94,000 $8.32 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Account

Avidity Partners Management LP Abb Vie Inc. Transaction History